Welcome to our new website! Let us know what you think..

Register to get unlimited access to all of Citywire’s Fund Manager database. Registration is free and only takes a minute.

The Expert View: AstraZeneca, Resolution and Premier Oil

Our daily roundup of the best analyst commentary on shares, also including Tristel and Xeros.

If you’d like to receive news alerts on any of the stocks mentioned in The Expert View, click on the star icons below to add them to your favourites.
Leave a comment
Key stats
Market capitalisation£58,718m
No. of shares out1,261m
No. of shares floating2,502m
No. of common shareholdersnot stated
No. of employees51700
Trading volume (10 day avg.)4m
Turnover15,301m USD
Profit before tax1,521m USD
Earnings per share1.21 USD
Cashflow per share3.40 USD
Cash per share4.74 USD

*Correct as at 28 Apr 2014

Liberum says Pfizer needs to go higher for Astra takeover

Shares in AstraZeneca (AZN.L) rocketed yesterday after Pfizer confirmed it had made a tentative takeover bid, but analysts at Liberum believe Astra’s US rival will need to cough up more money if it is to seal the huge deal.

AstraZeneca yesterday jumped 605.1p, or 14.8% to £46.85 after Pfizer said it had approached Astra in January with an offer valuing it at £46.61, representing a 30% premium on its 2 January share price.

Investors are now awaiting a fresh bid from Pfizer, which has said it would base a future bid on Astra’s 17 April share price. A 30% premium on that price would value the company at £49.15 per share.

Liberum analyst Naresh Chouhan said that price would likely prove unacceptable to Astra. ‘We believe a bid is unlikely at the implied Pfizer offer of £49.15 because AZN will be unwilling to accept that price and Pfizer will not want to go hostile,’ he said.

‘The £49.15 potential bid significantly undervalues AZN. Pfizer makes a strong case for the deal which would benefit both shareholders (AZN shareholders would receive majority paper, we believe) and hence a price closer to £60 would offer good value for AZN shareholders in our opinion.’

Leave a comment
Key stats
Market capitalisation£4,228m
No. of shares out1,418m
No. of shares floating1,405m
No. of common shareholdersnot stated
No. of employees3872
Trading volume (10 day avg.)5m
Turnover£10,989m
Profit before tax£204m
Earnings per share14.38p
Cashflow per share50.96p
Cash per share353.30p

*Correct as at 28 Apr 2014

Cash-rich Resolution a ‘buy’ for Deutsche

Deutsche Bank analyst Oliver Steel has upgraded Resolution (RSL.L) from ‘hold’ to 'buy’, pointing to the life insurer’s healthy cash reserves.

Steel said the group, a closed-book insurer, was facing headwinds in a weaker-than-expected underlying cashflow outlook and an implication that more acquisitions would be needed to meet dividend targets. Changes to pension rules that will remove the need for many to buy an annuity will exacerbate those problems, as will the City regulator’s plans to probe insurers’ historic pension sales.

But Steel said despite those clouds on the horizon, the level of cash the group was sitting on, coupled with a fall of around 15% in Resolution’s shares in the last six weeks, made it a ‘buy’.

‘Unallocated shareholder cash… looks set to be £520 million at end 2014,’ he said. ‘On top of this, the group has now confirmed it is looking to sell Lombard, which could bring in a further £300 million potentially. Were all this to be used for a share buy-back, we estimate it would be accretive to cash flow per share to the tune of 17%. In reality, management appears more minded to go down the mergers and acquisitions route; this too could bring benefits.’

Steel has placed a target price of 320p on the shares. Yesterday they were up 3.5p, or 1.2%, at 297.9p.

Leave a comment
Key stats
Market capitalisation£1,739m
No. of shares out527m
No. of shares floating508m
No. of common shareholdersnot stated
No. of employees732
Trading volume (10 day avg.)2m
Turnover893m USD
Profit before tax139m USD
Earnings per share0.26 USD
Cashflow per share0.65 USD
Cash per share0.50 USD

*Correct as at 28 Apr 2014

Premier Oil merger wouldn’t be so slick, says Canaccord

Canaccord Genuity analysts have reduced their target price for merger target Premier Oil (PMO.L) due to uncertainties over its Sea Lion oil discovery project in waters north of the Falkland Islands.

Analysts Thomas Martin and Charlie Sharp have knocked 50p off the target price for the shares, bringing it down to 375p, but maintained it as a ‘buy’. Premier Oil yesterday added 3.1p, or 1%, to reach 329.8p.

Premier has been the subject of a merger bid from smaller rival Ophir Energy, which it rejected. Martin and Sharp were sceptical of Ophir’s claims that the merger would produce a ‘well-funded, refocused, full cycle exploration and production company’ and said doubts over Sea Lion had led to the price cut.

Premier said in February it would be looking for a ‘farm-out’ partner to join forces with on the Sea Lion development. ‘Up until now our risked net asset value has been priced upon Premier carrying its current 60% equity interest in the project through to first oil,’ Martin and Sharp said.

‘We revise our net asset value to incorporate an assumed farm-out and revised risk assumptions, incorporating the chances of securing a farm-out partner.’

Leave a comment
Key stats
Market capitalisation£21m
No. of shares out40m
No. of shares floating23m
No. of common shareholdersnot stated
No. of employees92
Trading volume (10 day avg.)0m
Turnover£11m
Profit before tax£-1m
Earnings per share-3.16p
Cashflow per share-0.71p
Cash per share1.57p

*Correct as at 28 Apr 2014

Trio of upgrades for buoyant Tristel

FinnCap analyst Keith Redpath has upgraded his forecasts for Tristel (TSTL.L) for the third time in fourth months, as the AIM-listed healthcare equipment supplier builds on its strong performance.

Redpath has raised his target price from 52p to 63p after the company announced it expected to report profits of no less than £1.5 million for the year ending 30 June, ahead of the £1.3 million FinnCap had been expecting. Shares yesterday jumped 5.5p, or 11.3%, to 54p.

FinnCap has raised its forecast for 2014 in line with the new guidance, and upped its profit forecast for 2015 from £1.4 million to £1.8 million. With these new forecasts, its target price values Tristel on a price-earnings ratio of 17.8 times.

‘We believe these multiples are appropriate for the high-growth, cash generative, dividend-paying and debt-free company that Tristel has now become,’ Redpath said. ‘Given the recent history of upgrades, the risk to our estimates is firmly on the upside.’

Leave a comment
Key stats
Market capitalisation£65m
No. of shares out65m
No. of shares floating41m
No. of common shareholdersnot stated
No. of employees35
Trading volume (10 day avg.)0m
Turnover£0m
Profit before tax£-3m
Earnings per share-4.99p
Cashflow per share-4.92p
Cash per share13.03p

*Correct as at 28 Apr 2014

Jefferies predicts Xeros will clean up

Jefferies has kicked off its coverage of Xeros (XSG.L) will a ‘buy’ rating, arguing the cleaning technology company is ‘ready to put laundry into a spin’.

Xeros has invented a near-waterless washing, floated on AIM earlier this year. Jefferies has placed a 164p target price on the shares, which yesterday were up 3.7p, or 3.8%, at 99p.

‘Xeros has a patented polymer bead technology that can replace water in cleaning processes,’ said Jefferies analyst Joe Spooner. ‘The group is initially focused on laundry applications. It can demonstrate significant benefits from use, has large end markets in its sights and, as a completely new approach, we believe its technology has the potential to change industries.’

Leave a comment
Your Business: Cover Star Club

Profile: Quilter Cheviot boss Baines sees more consolidation ahead

Profile: Quilter Cheviot boss Baines sees more consolidation ahead

Nineteen months on from the merger of Quilter Cheviot chief executive Martin Baines says the deal is now paying dividends.

Wealth Manager on Twitter